Article Information
PubMed
Published By
History
- Received August 11, 2003
- Revision received December 1, 2004
- Accepted December 2, 2004
- First published February 16, 2005.
- Version of record published February 16, 2005.
Copyright & Usage
Copyright © 2005 Society for Neuroscience 0270-6474/05/251682-09.00/0
Author Information
- Paul Fernyhough1,2,3,
- Darrell R. Smith1,
- Jason Schapansky2,
- Randy Van Der Ploeg1,2,
- Natalie J. Gardiner3,
- Christopher W. Tweed3,
- Andreas Kontos3,
- Lyle Freeman3,
- Tertia D. Purves-Tyson3, and
- Gordon W. Glazner1,2
- 1Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada R2H 2A6, 2Division of Neurodegenerative Disorders, St. Boniface Research Centre, Winnipeg, Manitoba, Canada R2H 2A6, and 3School of Biological Sciences, University of Manchester, Manchester M13 9PT, United Kingdom
Author contributions
Disclosures
- Received August 11, 2003.
- Revision received December 1, 2004.
- Accepted December 2, 2004.
This work was supported by grants from the Manitoba Health Research Centre (G.W.G.), Canadian Institutes of Health Research (G.W.G.), and Wellcome Trust (P.F.).
Correspondence should be addressed to Dr. Gordon W. Glazner, St. Boniface Hospital Research Centre, 4052-351 Tache Avenue, Winnipeg, Manitoba, Canada R2H 2A6. E-mail: gglazner{at}sbrc.ca.
Copyright © 2005 Society for Neuroscience 0270-6474/05/251682-09$15.00/0
Online Impact